IOVS AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2003;44:4613-4621.)
© 2003 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-0112

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blackburn, J.
Right arrow Articles by Gregory-Evans, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blackburn, J.
Right arrow Articles by Gregory-Evans, K.

Transcriptional Regulation and Expression of the Dominant Drusen Gene FBLN3 (EFEMP1) in Mammalian Retina

James Blackburn,1 Emma E. Tarttelin,2 Cheryl Y. Gregory-Evans,1 Mariya Moosajee,1 and Kevin Gregory-Evans3

1From the Departments of Cell and Molecular Biology, 2Integrative and Molecular Neuroscience, and 3Ophthalmology, Faculty of Medicine, Imperial College London, London, United Kingdom.

PURPOSE. To determine the important transcriptional control elements and sites of expression of fibulin-3 in mammalian retina.

METHODS. Sequencing and 5' rapid amplification of cDNA ends (RACE) were undertaken to characterize the genomic sequence upstream of the FBLN3 coding sequence. Reporter deletion–mutation constructs were used in luciferase transfection assays to determine the important regulatory motifs. Fibulin-3 expression in mouse and human retina was studied by in situ hybridization and RT-PCR. The effect of 17ß-estradiol on fibulin-3 production was studied in COS-7 and ARPE-19 cells.

RESULTS. Two untranslated exons were fully sequenced completing the characterization of FBLN3 that comprises 12 exons. Reporter assays suggest that the FBLN3 proximal promoter is contained within 425 bp upstream of exon 1. Important regulatory elements include three Sp1-binding sites, a Tant motif (trans-activating) and an estrogen response element (ERE) binding site (trans-repressing). No TATA or CAAT regulatory boxes were identified. RT-PCR suggests that the fibulin-3 gene is expressed in murine and human RPE, and in situ studies confirm that Fbln3 is expressed in the outer and inner nuclear layers, but strikingly not in the ganglion cell layer. Fibulin-3 expression in ARPE-19 cells could be modified by varying the amount of estrogen in the cell culture medium.

CONCLUSIONS. The 5' end of the FBLN3 gene has been characterized, and the important upstream motifs regulating its transcription have been identified. Fibulin-3 is expressed in adult retina and at early stages in human and mouse development. Estrogen may be an important regulator of fibulin-3 expression, and this highlights a novel mechanism by which circulating estrogen may control the composition of the retinal extracellular matrix.





This article has been cited by other articles:


Home page
Hum Mol GenetHome page
L. Fu, D. Garland, Z. Yang, D. Shukla, A. Rajendran, E. Pearson, E. M. Stone, K. Zhang, and E. A. Pierce
The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice
Hum. Mol. Genet., October 15, 2007; 16(20): 2411 - 2422.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Y. Marmorstein, P. J. McLaughlin, N. S. Peachey, T. Sasaki, and A. D. Marmorstein
Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration
Hum. Mol. Genet., October 15, 2007; 16(20): 2423 - 2432.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Kobayashi, G. Kostka, J. H. O. Garbe, D. R. Keene, H. P. Bachinger, F.-G. Hanisch, D. Markova, T. Tsuda, R. Timpl, M.-L. Chu, et al.
A Comparative Analysis of the Fibulin Protein Family: BIOCHEMICAL CHARACTERIZATION, BINDING INTERACTIONS, AND TISSUE LOCALIZATION
J. Biol. Chem., April 20, 2007; 282(16): 11805 - 11816.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Xiang, T. Sekine, H. Nakamura, S. Imajoh-Ohmi, H. Fukuda, K. Yudoh, K. Masuko-Hongo, K. Nishioka, and T. Kato
Fibulin-4 is a target of autoimmunity predominantly in patients with osteoarthritis.
J. Immunol., March 1, 2006; 176(5): 3196 - 3204.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
M. Moosajee
Genes and the eye
J R Soc Med, May 1, 2005; 98(5): 206 - 207.
[Full Text] [PDF]


Home page
IOVSHome page
M. V. Miceli and S. M. Jazwinski
Nuclear Gene Expression Changes Due to Mitochondrial Dysfunction in ARPE-19 Cells: Implications for Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1765 - 1773.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C.-M. Li, J. B. Presley, X. Zhang, N. Dashti, B. H. Chung, N. E. Medeiros, C. Guidry, and C. A. Curcio
Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy
J. Lipid Res., April 1, 2005; 46(4): 628 - 640.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. W. Pickrell, X. Zhu, X. Wang, and C. M. Craft
Deciphering the Contribution of Known cis-Elements in the Mouse Cone Arrestin Gene to its Cone-Specific Expression
Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 3877 - 3884.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. A. Klenotic, F. L. Munier, L. Y. Marmorstein, and B. Anand-Apte
Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) Is a Binding Partner of Epithelial Growth Factor-containing Fibulin-like Extracellular Matrix Protein 1 (EFEMP1): IMPLICATIONS FOR MACULAR DEGENERATIONS
J. Biol. Chem., July 16, 2004; 279(29): 30469 - 30473.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association for Research in Vision and Ophthalmology